Skip to main content

Calcium Antagonistic Activity and Myocardial Ischemic Protection by Both Stereoisomers of Verapamil

  • Chapter
Advances in Myocardiology

Abstract

The effects of the optical isomers of verapamil were compared on intact and partially ischemic pig hearts as well as on vascular smooth muscle of rabbits and rats. In K+-depolarized strips of rabbit mesenteric artery, both isomers shifted calcium dose-response curves (tension development) in a qualitatively similar manner to the right, with threshold concentrations of 10–8 m (—)verapamil and 10–7 m (+)verapamil. In K+-depolarized rat aortic strips, the calcium antagonistic activity was quantified. (+)Verapamil was at least as potent as several other coronary drugs [(±)verapamil = 1]: perhexiline 0.02, prenylamine 0.05, fendiline 0.05, diltiazem 0.15, (±)verapamil 0.15, (-)verapamil 1.5. The optical isomers of D600 showed a considerably greater difference in calcium antagonistic potency (about a factor of 60) as compared to verapamil (factor of 10). In the pig heart, reversible and reproducible ischemia reactions were provoked by repeated occlusions (3 min) of a branch of the LAD followed by reperfusion for 15 min. In the tested range of 0.4–2.0 mg/kg i.V., (-I-)verapamil dose-dependently reduced ischemic ST elevations in four epicardial leads. At an intermediate dose of 1 mg/kg, (+Verapamil diminished ST-elevations by 32% (occlusion 11 min p.i.). Results not statistically different were obtained with 0.1 mg/kg (-)verapamil (28%) and 0.2 mg/kg (±)verapamil (40%). No qualitative differences between the isomers could be observed with regard to hemodynamic parameters with equieffective reduction of the ischemia reaction: slight decrease in heart rate; prolongation of PQ duration with only minimal and insignificant effect of (+)verapamil; decrease of systolic and diastolic blood pressure, left ventricular pressure, and LV dp/dt max . In contrast to optically active and racemic verapamil, nifedipine in a hypotensive dose (0.05 mg/kg i.v.) increased heart rate and diminished ischemic ST elevations only moderately (13%). The results obtained on vascular smooth muscle and ischemic pig heart clearly show that there are no remarkable qualitative differences between verapamil enantiomers. It can be concluded that (+)verapamil, by its calcium antagonistic properties, contributes to the therapeutic efficacy of the racemic drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bayer, R., Kalusche, D., Kaufmann, R., and Mannhold, R. 1975. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials. Naunyn Schmiedebergs Arch. Pharmacol.290:81–97.

    Article  PubMed  CAS  Google Scholar 

  2. Bayer, R., Kaufmann, R., and Mannhold, R. 1975. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers. Naunyn Schmiedebergs Arch. Pharmacol.290:69–80.

    Article  PubMed  CAS  Google Scholar 

  3. Chiba, S., Kobayashi, M., and Furukawa, Y. 1978. Effects of optical isomers of verapamil on SA nodal pacemaker activity and contractility of the isolated dog heart. Jpn. Heart J.19:409–414.

    Article  PubMed  CAS  Google Scholar 

  4. Fleckenstein, A. 1971. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: P. Harris and L. Opie (eds.), Calcium and the Heart, pp. 135–188. Academic Press, New York.

    Google Scholar 

  5. Kaumann, A. J., and Serur, J. R. 1975. Optical isomers of verapamil on canine heart. Prevention of ventricular fibrillation induced by coronary artery occlusion, impaired atrioventricular conductance and negative inotropic and chronotropic effects. Naunyn Schmiedebergs Arch. Pharmacol.291:347–358.

    Article  PubMed  CAS  Google Scholar 

  6. Ludwig, C, and Nawrath, H. 1977. Effects of D 600 and its optical isomers on force of contraction in cat papillary muscles and guinea-pig articles. Br. J. Pharmacol.59:411–417.

    Article  PubMed  CAS  Google Scholar 

  7. Nawrath, H., Blei, J., Gegner, R., Ludwig, C, and Zong, X. 1981. No stereospecific effects of the optical isomers of verapamil and D-600 on the heart. In: A. Zanchetti and D. M. Krikler (eds.), Calcium Antagonism in Cardiovascular Therapy, Experience with Verapamil. Internat. Symposium, Florence. 2nd-4th October, 1980, pp. 52–63, Excerpta Medica, Amsterdam-Oxford-Princeton.

    Google Scholar 

  8. Nayler, W. G., Mas-Oliva, J., and Williams, A. J. 1980. Cardiovascular receptors and calcium. Circ. Res.46(Suppl. 1): 161–166.

    Article  CAS  Google Scholar 

  9. Raschack, M., and Engelmann, K. 1980. Calcium-antagonistic activity and myocardial ischemia protection by both stereoisomers of verapamil. J. Mol. Cell. Cardiol.12(Suppl. 1):132.

    Google Scholar 

  10. Satoh, K., Yanagisawa, T., and Taira, N. 1979. Effects of atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dog. Naunyn Schmiedebergs Arch. Pharmacol.308:89–98.

    Article  PubMed  CAS  Google Scholar 

  11. Satoh, K., Yanagisawa, T., and Taira, N. 1980. Coronary vasodilator and cardiac effects of optical isomers of Verapamil in the dog. J. Cardiovasc. Pharmacol.2:309–318.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Raschack, M., Engelmann, K. (1983). Calcium Antagonistic Activity and Myocardial Ischemic Protection by Both Stereoisomers of Verapamil. In: Chazov, E., Saks, V., Rona, G. (eds) Advances in Myocardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4441-5_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4441-5_48

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-4443-9

  • Online ISBN: 978-1-4757-4441-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics